Damora Therapeutics, Inc. (DMRA) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
Damora Therapeutics, Inc. (DMRA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $566.00K. See net asset quality index of Damora Therapeutics, Inc. to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$566.00K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Damora Therapeutics, Inc. (None–None)
Year-by-year capital reinvestment analysis for Damora Therapeutics, Inc.. For live market cap and broader valuation context, see Damora Therapeutics, Inc. stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow